Jump to content

Stable Scans


bbw1

Recommended Posts

I received the results from my CT Scan yesterday that shows all tumors stable, no significant shrinkage or progression, praise God. The doctor suggested another weekly series (6) of Topotecan starting next week. Can anyone share their experiences with Topotecan? So far hair is growing back, no bone pain, minimal side effects, but no shrinkage.

Link to comment
Share on other sites

Dave just started topotecan, I think this week was his second treatment. He had some nausea yesterday but nothing terrible. His first treatment, he also had zometa, an IV drug for bone growth, and he had awful bone pain for a week after that, and that was a side effect of the zometa we found out. he hasn't had that this time, but he's also taking oxycontin this time.

Dave's first chemo was carboplatin and VP-16 and that seemed to work well, he was in remission for just about a year, although it did come back . . . have you tried that?

have you had a PET scan or a bone scan?

Blessings,

Karen

Link to comment
Share on other sites

Thanks Karen and all for your responses. My initial 2 treatments were carboplatin and etoposide. Favorable response (shrinkage) in lymph nodes and lung but liver enzymes went extremely high. Doctor changed treament to taxol based on liver functions. I have always wondered which chemo caused the liver enzyme issue vs the tumor shrinkage.

Bone scan done about 4 weeks ago- all clear.

No PET Scan.

God Bless,

Blaine

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.